Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0014070 (
encephalomyelitis
)
13,017
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Specific oligonucleotide primers were used to identify and isolate
IFN-gamma-inducing factor
(
IGIF
) from the brain of rats with developing experimental autoimmune
encephalomyelitis
(EAE), a T cell-mediated autoimmune disease of the central nervous system that serves as a model for multiple sclerosis.
IGIF
was highly transcribed in the brain at the onset and during the course of active EAE. PCR products encoding rat
IGIF
were used to generate the recombinant protein that was used to induce anti-
IGIF
neutralizing Abs. These Abs significantly reduced the production of IFN-gamma by primed T cells proliferating in response to their target myelin basic protein epitope and by Con A-activated T cells from naive donors. When administered to rats during the development of either active or transferred EAE, these Abs significantly blocked the development of disease. Splenic T cells from protected rats were cultured with the encephalitogenic myelin basic protein epitope and evaluated for production of IL-4 and IFN-gamma. These cells, which proliferated, exhibited a profound increase in IL-4 production that was accompanied by a significant decrease in IFN-gamma and TNF-alpha production. Thus, we suggest that perturbation of the Th1/Th2 balance toward Th2 cells is the mechanism underlying EAE blockade by anti-
IGIF
immunotherapy.
...
PMID:Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. 983 27
T helper type 1 (T(H)1) lymphocytes are considered to be the main pathogenic cell type responsible for organ-specific autoimmune inflammation. As
interleukin 18
(
IL-18
) is a cofactor with IL-12 in promoting T(H)1 cell development, we examined the function of
IL-18
and its receptor, IL-18R, in autoimmune central nervous system inflammation. Similar to IL-12-deficient mice,
IL-18
-deficient mice were susceptible to experimental autoimmune
encephalomyelitis
. In contrast, IL-18R alpha-deficient mice were resistant to experimental autoimmune
encephalomyelitis
, indicating involvement of an IL-18R alpha ligand other than
IL-18
with encephalitogenic properties. Moreover, engagement of IL-18R alpha on antigen-presenting cells was required for the generation of pathogenic IL-17-producing T helper cells. Thus,
IL-18
and T(H)1 cells are dispensable, whereas IL-18R alpha and IL-17-producing T helper cells are required, for autoimmune central nervous system inflammation.
...
PMID:Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. 1690 65